FibroBiologics, Inc. - COM NEW (FBLG)

CUSIP: 31573L204

Q2 2026 13F Holders as of 30 Jun 2026

Share change
+100
SEC-reported price per share
$0.95
Number of holders
1
Value change
+$95
Number of buys
1

Security key

31573L204

Report period

Q2 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of FBLG - FibroBiologics, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Pete O'Heeron
Disclosed value leader
Pete O'Heeron
Comparable rows
4/15
Latest evidence
04 May 2026
13D/G 3/4/5 13F Lead comparable stake: 18% 11 rows are not safely comparable across share classes. 13D/G row: Pete O'Heeron Showing 1-6 of 15 holder rows.

Quick read

Pete O'Heeron leads the comparable SEC ownership view at 18%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pete O'Heeron's linked filing trail.
Comparable ownership Top 4
Pete O'Heeron 18%
Michael F. Newlin 5.6%
Lind Global Fund III LP 5%
BlackRock, Inc. 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Pete O'Heeron
13D/G 3/4/5
CHIEF EXECUTIVE OFFICER, Director
18%
$7,229,517
6,951,459 shares
$0 31 Jan 2024
Michael F. Newlin
13D/G
Mike Newlin
5.6%
$1,857,322
2,134,853 shares
$0 09 Aug 2024
Lind Global Fund III LP
13D/G
5%
$78,280
230,234 shares
$0 02 Apr 2026
BlackRock, Inc.
13D/G 13F
Company
2%
$467,209
750,898 shares
-$644,162 30 Jun 2025
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
class O/S missing
$89,318
67,665 shares
31 Mar 2026
Fund Evaluation Group, LLC
13F
Company
13F
class O/S missing
$68,368
51,794 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
100
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
16
Q2 2026 holders
1
Holder diff
-15
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .